Australia

Alterity Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference

MELBOURNE, Australia, Jan. 5, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced thatDavid Stamler, M.D., Chief Executive Of...

2022-01-05 20:45 3175

IMTE raise funds to support the acquisition and building out of manufacturing infrastructure

SYDNEY, Jan. 5, 2022 /PRNewswire/ -- Integrated Media Technology Limited ("IMTE" or "Company") (Nasdaq:IMTE), informs that the Company raise funds to support the acquisition and building out of manufacturing infrastructure.  On January 3, 2022, the Company entered into convertible note purchase...

2022-01-05 20:44 3096

IMTE to divest its Lamination Glass operation in China

SYDNEY, Jan. 4, 2022 /PRNewswire/ -- Integrated Media Technology Limited ("IMTE" or "Company") (Nasdaq:IMTE), informs that today its Board of Directors approved a plan to divest itsChina lamination glass operation.  IMTE intends to divest from its China electronic glass business by either sel...

2022-01-04 21:26 3205

Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines

* US Patent and Trademark Office has granted Exopharm patent US 11202805, for its LEAP™ exosome purification technology. * LEAP™ enables large-scale, clinical grade commercial production of exosomes needed to underpin the emerging field of exosome medicines. * Exopharm is seeking potential p...

2021-12-22 19:00 1833

First Patient Dosed in Australia in ATG-101 First-in-Human Trial

SHANGHAI AND HONG KONG, Dec. 19, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and onco...

2021-12-20 10:56 2572

Bionomics Limited Announces Pricing of Initial Public Offering in the United States

ADELAIDE, Australia, Dec. 16, 2021 /PRNewswire/ -- Bionomics Limited (Bionomics orCompany), a clinical-stage biopharmaceutical company, today announced the pricing of its initial public offering inthe United States (the Offering) of 1,622,000 American Depositary Shares (ADSs), each representing 1...

2021-12-16 19:00 2450

Awards and Demand for Process Automation Software Propels Nintex into 2022

Industry recognition for Nintex and its commitment to customer success paves the way for organisations to accelerate digital transformation in the New Year with the easy-to-use and powerful capabilities of the Nintex Process Platform MELBOURNE, Australia, Dec. 16, 2021 /PRNewswire/ -- Nintex, the...

2021-12-16 06:05 1872

FDA Breakthrough Devices Designation Application to Fast-Track Painful Finger-Prick Alternative for People Living with Diabetes

SYDNEY, Dec. 15, 2021 /PRNewswire/ -- Life Science Biosensor Diagnostics Pty Ltd (LSBD), a life sciences and medical technology company and subsidiary of The iQ Group Global, announced it has filed an application with the U.S Food and Drug Administration (FDA) for Breakthrough Devices Designation...

2021-12-15 21:01 1437

Info-Tech Research Group Reveals 2022 Tech Trends

SYDNEY, Dec. 15, 2021 /PRNewswire/ -- Info-Tech Research Group, one of the fastest-growing information technology and research advisory firms in the world, has revealed its annual tech trend insights for the coming year. Info-Tech offers research, diagnostics, and workshops to systematically impr...

2021-12-15 06:00 2439

App Annie and AppsFlyer's State of App Marketing report Explores the Rise of the 'App Tourist' in ANZ

SYDNEY, Dec. 15, 2021 /PRNewswire/ -- App Annie, the leading mobile data and analytics company, andAppsFlyer, the marketing measurement and experience platform, have released a report on theState of App Marketing in Australia & New Zealand, exploring the impact of the COVID-19 pandemic on the loc...

2021-12-15 05:00 2714

Alterity Therapeutics Announces First Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial

MELBOURNE, Australia, Dec. 14, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today announced that the New Zealand Medicines and Medic...

2021-12-14 20:25 1670

CSL Limited Announces Tender Offer To Acquire Vifor Pharma Ltd

MELBOURNE, Australia and ST. GALLEN, Switzerland, Dec. 14, 2021 /PRNewswire/ -- CSL Limited Announces Tender Offer To Acquire Vifor Pharma Ltd - Agreement Announced on the Australian Stock Exchange and SIX Swiss Exchange 14 December, 2021 - Expands CSL's leadership across an attractive portfolio ...

2021-12-14 14:59 1830

KAZIA THERAPEUTICS APPOINTS KAREN KRUMEICH AS CHIEF FINANCIAL OFFICER

SYDNEY, Dec. 13, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the appointment ofKaren Krumeich as Chief Financial Officer. In this role, Ms Krumeich will focus on building and maintaining relatio...

2021-12-14 00:00 2832

JustGiving® from Blackbaud® is Now Fully Fee-Free for Australian Charity Organisations

Historic First in Online Giving for Australia-Based Fundraising Solution SYDNEY, Dec. 12, 2021 /PRNewswire/ -- Blackbaud (NASDAQ: BLKB), the world's leading cloud software company powering social good, has announced that its peer-to-peer fundraising solution, JustGiving® from Blackbaud®, is now f...

2021-12-13 06:00 2737

Ironbark Raises $4m to Continue Citronen Project Finance Activity in 2022

PERTH, Australia, Dec. 9, 2021 /PRNewswire/ -- Ironbark Zinc Limited ( "Ironbark", "the Company" or "IBG") is pleased to update its shareholders with respect to its recently completed capital raise. Highlights * Very strongly supported capital raise completed with $4 million in firm commitmen...

2021-12-10 12:40 1486

Trajan to acquire LEAP PAL Parts

MELBOURNE, Australia, Dec. 9, 2021 /PRNewswire/ -- Global analytical science and device company Trajan Group Holdings Limited (ASX: TRJ) (Trajan or the Company) has entered into a binding agreement to acquire the business of LEAP PAL Parts and Consumables, LLC ("LPP"), based in Raleigh North Caro...

2021-12-09 21:00 1857

US EXIM Bank Issues Ironbark Zinc (ASX:IBG) with Preliminary Funding Approval

Highlights * US EXIM has issued Ironbark with a Preliminary Project Letter (PPL) offering up toUS$657m in debt funding to cornerstone the development of the Citronen Project * Key commercial details of the indicative Term Sheet include (all dollar figures USD): - Loan Amount – up to $657m co...

2021-12-08 10:36 2252

Wise-Sync Settles Legal Claims with NVoiceFlow

MELBOURNE, Australia, Dec. 7, 2021 /PRNewswire/ -- Wise-Sync has settled its claims in the Supreme Court ofVictoria against its former customer Linden Technology Group (T/AS Lindentech), Nvoiceflow Pty Ltd and their common managing directorJawid Dadarkar. Wise-Sync alleged that Nvoiceflow was cr...

2021-12-07 14:16 1995

2021 Imperial Springs International Forum Opened in Guangzhou, China

GUANGZHOU, China, Dec. 6, 2021 /PRNewswire/ -- Themed "Multilateralism 2.0: Global Cooperation in the Post-Pandemic Era", the 2021 Imperial Springs International Forum was scheduled fromDec. 5 to 6 in the southern Chinese city ofGuangzhou. The event attracted over 150 guests from political, aca...

2021-12-07 12:25 1859

Ho Ho (Oh No!) 2021's Hardest Holiday Conversation: Covid Testing Card Campaign Launches to Humorously Handle Australians' Most Uncomfortable Holiday Ask

SYDNEY, Dec. 7, 2021 /PRNewswire/ -- According to new research from Rapid Test & Trace Australia, only 42.6% of Australians plan to ask family and friends to get a COVID test to ensure safety before holiday visits. Even more shockingly, 6.6% of Australians say 'they could never ask them to get a C...

2021-12-07 07:38 1192
1 ... 23242526272829 ... 55